Therapy to Maintain Remission in Dilated Cardiomyopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Therapy to Maintain Remission in Dilated Cardiomyopathy — Stella

Home/Heart Failure/

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Royal Brompton Hospital, London

Key details

Sponsor

Imperial College London

Collaborators

Royal Brompton & Harefield NHS Foundation Trust

Enrollment target

~50 participants

Started

December 2023

Primary completion

August 2026

Age range

18 Years – 85 Years

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.